| Size | Price | Stock |
|---|---|---|
| 500μg | $160 | Get quote |
| 1mg | $250 | In-stock |
| 5 mg | Get quote | |
| 10 mg | Get quote | |
| We match the lowest price on market. | ||
We offer a substantial discount on larger orders, please inquire via [email protected]
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
| Cat. No. : | HY-103322 |
| M.Wt: | 455.29 |
| Formula: | C17H15N5NaO7P |
| Purity: | >98 % |
| Solubility: | 10 mM in DMSO |
6-Bnz-cAMP sodium, a derivative of cyclic adenosine monophosphate (cAMP), is a selective PKA activator with inhibitory activity against the bTREK-1 K+ channel. 6-Bnz-cAMP sodium does not activate the Epac signaling pathway. 6-Bnz-cAMP sodium inhibits the bTREK-1 K+ channel via a voltage-independent, ATP-dependent mechanism that is independent of the PKA/Epac/calmodulin kinase/MAP kinase pathway. 6-Bnz-cAMP sodium activates CREB phosphorylation to regulate osteoblast-specific gene expression, induces osteoblast differentiation, promotes extracellular matrix mineralization, supports osteoblast proliferation, and shows no cytotoxicity toward osteoblasts. 6-Bnz-cAMP sodium can be used in studies related to bone tissue repair and regeneration[1][2][3].
In Vitro:6-Bnz-cAMP (100 μM) sodium induces 44.9% relaxation of α-toxin-permeabilized human detrusor smooth muscle strips contracted by 1 μM [Ca2+]ᵢ, with a potency comparable to cAMP[1].
6-Bnz-cAMP (<0.2-100 μM; 1-20 min) sodium potently inhibits bTREK-1 K+ channels in primary bovine AZF cells via an ATP-dependent, voltage-independent, PKA- and Epac-independent mechanism, with an IC50 of less than 0.2 μM when applied intracellularly[2].
6-Bnz-cAMP (100 µM; 7-21 days) sodium supports proliferation of osteoblast-like MC3T3-E1 cells and maintains >90% cell viability over 21 days without inducing cytotoxicity[3].
6-Bnz-cAMP (100 µM; 7 days) sodium induces Runx2 protein expression in osteoblast-like MC3T3-E1 cells after 7 days of incubation[3].
6-Bnz-cAMP (100 µM; 7-14 days) sodium significantly enhances ALP activity in osteoblast-like MC3T3-E1 cells at 7 and 14 days of incubation[3].
6-Bnz-cAMP (100 µM; 18 days) sodium promotes production of extracellular OCN and OPN proteins in osteoblast-like MC3T3-E1 cells after 18 days of incubation[3].
6-Bnz-cAMP (100 µM; 21 days) sodium significantly enhances extracellular matrix calcium deposition (mineralization) in osteoblast-like MC3T3-E1 cells after 21 days of incubation in mineralization medium[3].
6-Bnz-cAMP (100 µM; 1-7 days) sodium activates phosphorylation of CREB in osteoblast-like MC3T3-E1 cells at 1 and 7 days of incubation, while inducing osteoblastic differentiation independent of Erk phosphorylation[3].
Lorem ipsum dolor sit amet, consectetur adipisicing elit. Autem earum hic iste maiores, nam neque rem suscipit. Adipisci consequatur error exercitationem fugit ipsam optio qui, quibusdam repellendus sed vero! Debitis.
Inquiry Information
Your information is safe with us.